Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage

World Journal of Gastroenterology

Volumn 19, Issue 37, 2013, Pages 6131-6143

  Loffroy, Romaric ^a   Estivalet, Louis ^a   Cherblanc, Violaine ^a   Favelier, Sylvain ^a   Pottecher, Pierre ^a   Hamza, Samia ^a   Minello, Anne ^a   Hillon, Patrick ^a   Thouant, Pierre ^a   Lefevre, Pierre Henri ^a   Krausé, Denis ^a   Cercueil, Jean Pierre ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Cirrhosis; Portal hypertension; Transjugular intrahepatic portosystemic shunt; Variceal hemorrhage

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; ENBUCRILATE; OCTREOTIDE; QUINOLONE; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

ACOUSTIC RADIATION FORCE IMPULSE; ARTIFICIAL EMBOLISM; BACTERIAL INFECTION; BALLOON CATHETER; BALLOON TAMPONADE; BILIARY TRACT HEMORRHAGE; CANNULA; DOPPLER FLOWMETRY; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGEAL ULCERATION; ESOPHAGUS DISEASE; ESOPHAGUS VARICES BLEEDING; GASTRIC BALLOON; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEMATOMA; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; LIGATION; LIVER CIRRHOSIS; LIVER ISCHEMIA; LIVER VEIN; LIVER VEIN OBSTRUCTION; MESENTERIC ISCHEMIA; META ANALYSIS (TOPIC); MORTALITY; MULTIPLE ORGAN FAILURE; NEEDLE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTAL VEIN THROMBOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALVAGE THERAPY; SEPSIS; SHUNT THROMBOSIS; STOMACH ANTRUM VASCULAR ECTASIA; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME;

CIRRHOSIS; PORTAL HYPERTENSION; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARICEAL HEMORRHAGE;

EMERGENCIES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; PATIENT SELECTION; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84885626460     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i37.6131     Document Type: Review

References (90)

1. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000; 46 Suppl 3-4: III1-III15 [PMID: 10862604]
2. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319: 983-989 [PMID: 3262200 DOI: 10.1056/ NEJM198810133191505]
3. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354 [PMID: 7601427 DOI: 10.1002/hep.1840220145]
4. de Dombal FT, Clarke JR, Clamp SE, Malizia G, Kotwal MR, Morgan AG. Prognostic factors in upper G.I. bleeding. Endoscopy 1986; 18 Suppl 2: 6-10 [PMID: 3519197 DOI: 10.1055/s-2007-1018418]
5. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989; 96: 1552-1559 [PMID: 2785470]
6. McAvoy NC, Hayes PC. The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage. Eur J Gastroenterol Hepatol 2006; 18: 1135-1141 [PMID: 17033431 DOI: 10.1097/01. meg.0000236877.98472.58]
7. Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117: 626-631 [PMID: 10464138 DOI: 10.1016/S0016-5085(99)70455-5]
8. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213-218 [PMID: 6975734 DOI: 10.1016/S0016-5107(81)73224-3]
9. March RE, Kirwan JR, Davies PG, Winrow VR, Holborow EJ. Sensitive ELISA measurement of IgA, IgG and IgM antiglobulins in rheumatic and other diseases and a comparison of their specificity in rheumatoid arthritis and infectious mononucleosis. Scand J Rheumatol 1987; 16: 445-449 [PMID: 3501161 DOI: 10.1007/s00270-012-0493-y]
10. Pomier-Layrargues G, Bouchard L, Lafortune M, Bissonnette J, Guérette D, Perreault P. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status. Int J Hepatol 2012; 2012: 167868 [PMID: 22888442]
11. Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol 2011; 45: 133-148 [PMID: 21135706 DOI: 10.1097/MCG.0b013e3181fbe249]
12. Barange K, Péron JM, Imani K, Otal P, Payen JL, Rousseau H, Pascal JP, Joffre F, Vinel JP. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30: 1139-1143 [PMID: 10534333 DOI: 10.1002/hep.510300523]
13. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-987 [PMID: 9558287 DOI: 10.1016/S0016-5085(98)00640-4]
14. Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, Lin CK, Chan HH, Pan HB. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39: 679-685 [PMID: 17661241 DOI: 10.1055/s-2007-966591]
15. Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51: 270-274 [PMID: 12117893 DOI: 10.1136/gut.51.2.270]
16. Tesdal IK, Filser T, Weiss C, Holm E, Dueber C, Jaschke W. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology 2005; 236: 360-367 [PMID: 15955858 DOI: 10.1148/radiol.2361040530]
17. Azoulay D, Castaing D, Majno P, Saliba F, Ichaï P, Smail A, Delvart V, Danaoui M, Samuel D, Bismuth H. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35: 590-597 [PMID: 11690704]
18. D'Amico G, Luca A. TIPS is a cost effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varices. J Hepatol 2008; 48: 387-390 [PMID: 18199520 DOI: 10.1016/j.jhep.2007.12.009]
19. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, Cole PE. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111: 138-146 [PMID: 8698192 DOI: 10.1053/gast.1996.v111. pm8698192]
20. Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol 2002; 37: 703-704 [PMID: 12399244 DOI: 10.1016/S0168-8278(02)00321-5]
21. García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mössner J, Bosch J. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-2379 [PMID: 20573925 DOI: 10.1056/NEJMoa0910102]
22. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, Berger E, Blum U, Gabelmann A, Hauenstein K. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171 [PMID: 8264738 DOI: 10.1056/NEJM199401203300303]
23. Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Morgan DR, Ostroff JW, Rockey DC, Bacchetti P, LaBerge J, Lake JR, Somberg K, Doherty C, Davila M, McQuaid K, Wall SD. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126: 858-865 [PMID: 9163286 DOI: 10.7326/0003-4819-126-11-199706010-00002]
24. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Cole PE, Tisnado J, Simmons S. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126: 849-857 [PMID: 9163285 DOI: 10.7326/0003-4819-126-11-199706010-00001]
25. Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, Rodriguez SanRoman JL, Guerra C, Kravetz D. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110: 832-839 [PMID: 8608893 DOI: 10.1053/gast.1996.v110.pm8608893]
26. Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997; 113: 1623-1631 [PMID: 9352865 DOI: 10.1053/gast.1997.v113.pm9352865]
27. Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, MacGilchrist AJ, Finlayson ND, Hayes PC. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997; 26: 1115-1122 [PMID: 9362350 DOI: 10.1002/hep.510260505]
28. Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadori F, Meddi P, Primignani M, Pedretti G, Maggi A, Capocaccia L, Lovaria A, Ugolotti U, Salvatori F, Bezzi M, Rossi P. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998; 27: 48-53 [PMID: 9425916 DOI: 10.1002/hep.510270109]
29. Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein KH, Geiger R, Stiepak C, Keller W, Blum HE. Randomised trial of transjugular-intrahepaticportosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 349: 1043-1049 [PMID: 9107241]
30. García-Villarreal L, Martínez-Lagares F, Sierra A, Guevara C, Marrero JM, Jiménez E, Monescillo A, Hernández-Cabrero T, Alonso JM, Fuentes R. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999; 29: 27-32 [PMID: 9862845 DOI: 10.1002/hep.510290125]
31. Pomier-Layrargues G, Villeneuve JP, Deschênes M, Bui B, Perreault P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne MP. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001; 48: 390-396 [PMID: 11171831 DOI: 10.1136/gut.48.3.390]
32. Narahara Y, Kanazawa H, Kawamata H, Tada N, Saitoh H, Matsuzaka S, Osada Y, Mamiya Y, Nakatsuka K, Yoshimoto H, Koizumi N, Sakamoto C, Kobayashi M. A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res 2001; 21: 189-198 [PMID: 11673103 DOI: 10.1016/S1386-6346(01)00104-8]
33. Gülberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, Reiser M, Schild HH, Sauerbruch T, Gerbes AL. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol 2002; 37: 338-343 [PMID: 11916197 DOI: 10.1080/003655202317284255]
34. Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 2002; 37: 249-252 [PMID: 11916185 DOI: 10.1080/003655202317284138]
35. Zheng M, Chen Y, Bai J, Zeng Q, You J, Jin R, Zhou X, Shen H, Zheng Y, Du Z. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: metaanalysis update. J Clin Gastroenterol 2008; 42: 507-516 [PMID: 18344888 DOI: 10.1097/MCG.0b013e31815576e6]
36. Vangeli M, Patch D, Terreni N, Tibballs J, Watkinson A, Davies N, Burroughs AK. Bleeding ectopic varices--treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. J Hepatol 2004; 41: 560-566 [PMID: 15464235 DOI: 10.1016/j.jhep.2004.06.024]
37. Vidal V, Joly L, Perreault P, Bouchard L, Lafortune M, Pomier-Layrargues G. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients. Cardiovasc Intervent Radiol 2006; 29: 216-219 [PMID: 16284702 DOI: 10.1007/ s00270-004-0346-4]
38. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118: 905-911 [PMID: 10784589 DOI: 10.1016/S0016-5085(00)70176-4]
39. Spahr L, Villeneuve JP, Dufresne MP, Tassé D, Bui B, Willems B, Fenyves D, Pomier-Layrargues G. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44: 739-742 [PMID: 10205216 DOI: 10.1136/gut.44.5.739]
40. Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Gonzales Abraldes J, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008; 135: 808-815 [PMID: 18621047 DOI: 10.1053/ j.gastro.2008.05.051]
41. Hernández-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, García-Pagán JC. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004; 40: 1197-1202 [PMID: 15486923 DOI: 10.1002/hep.20436]
42. Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplant 2000; 25: 987-992 [PMID: 10800068 DOI: 10.1038/ sj.bmt.1702386]
43. Dhanasekaran R, West JK, Gonzales PC, Subramanian R, Parekh S, Spivey JR, Martin LG, Kim HS. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol 2010; 105: 635-641 [PMID: 19904245 DOI: 10.1038/ ajg.2009.634]
44. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: longterm results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13: 529-534 [PMID: 11396532 DOI: 10.1097/00042737-200105 000-00011]
45. Wilputte JY, Goffette P, Zech F, Godoy-Gepert A, Geubel A. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients. Acta Gastroenterol Belg 2007; 70: 6-10 [PMID: 17619531]
46. Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002; 13: 385-390 [PMID: 11932369 DOI: 10.1016/ S1051-0443(07)61741-2]
47. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47: 288-295 [PMID: 10896924 DOI: 10.1136/gut.47.2.288]
48. Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 2003; 50: 1753-1755 [PMID: 14696397]
49. Martinez-Palli G, Drake BB, Garcia-Pagan JC, Barbera JA, Arguedas MR, Rodriguez-Roisin R, Bosch J, Fallon MB. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol 2005; 11: 6858-6862 [PMID: 16425397]
50. Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK. The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol 2012; 199: 746-755 [PMID: 22997364 DOI: 10.2214/AJR.12.9101]
51. Kravetz D, Bosch J, Arderiu M, Pilar Pizcueta M, Rodés J. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology 1989; 9: 808-814 [PMID: 2714733 DOI: 10.1002/hep.1840090603]
52. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995; 108: 1828-1834 [PMID: 7768389 DOI: 10.1016/0016-508 5(95)90146-9]
53. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27: 1207-1212 [PMID: 9581672 DOI: 10.1002/hep.510270504]
54. Bernard B, Grangé JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29: 1655-1661 [PMID: 10347104 DOI: 10.1002/hep.510290608]
55. Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994; 20: 34-38 [PMID: 8020902 DOI: 10.1002/hep.1840200107]
56. Selby WS, Norton ID, Pokorny CS, Benn RA. Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. Gastrointest Endosc 1994; 40: 680-684 [PMID: 7859964]
57. Hsieh WJ, Lin HC, Hwang SJ, Hou MC, Lee FY, Chang FY, Lee SD. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998; 93: 962-966 [PMID: 9647029 DOI: 10.1111/j.1572-0241.1998.00288.x]
58. Young MF, Sanowski RA, Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc 1993; 39: 119-122 [PMID: 8495829 DOI: 10.1016/S0016-5107(93)70049-8]
59. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346: 865-868 [PMID: 7564670 DOI: 10.1016/S0140-6736(95)92708-5]
60. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 1997; 350: 1495-1499 [PMID: 9388396 DOI: 10.1016/ S0140-6736(97)05099-X]
61. Calès P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki JP, Ribard D, Botta-Fridlund D, Hillon P, Besseghir K, Lebrec D. Early administration of vapreotide for variceal bleeding in patients with cir-rhosis. N Engl J Med 2001; 344: 23-28 [PMID: 11136956 DOI: 10.1056/NEJM200101043440104]
62. Sung JJ, Chung SC, Yung MY, Lai CW, Lau JY, Lee YT, Leung VK, Li MK, Li AK. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346: 1666-1669 [PMID: 8551824 DOI: 10.1016/S0140-6736(95)92840-5]
63. Bañares R, Albillos A, Rincón D, Alonso S, González M, Ruiz-del-Arbol L, Salcedo M, Molinero LM. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35: 609-615 [PMID: 11870374 DOI: 10.1053/jhep.2002.31354]
64. Panés J, Terés J, Bosch J, Rodés J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988; 33: 454-459 [PMID: 3280273 DOI: 10.1007/BF01536031]
65. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, Marrero JM, Buceta E, Sánchez J, Castellot A, Peñate M, Cruz A, Peña E. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40: 793-801 [PMID: 15382120 DOI: 10.1002/hep.20386]
66. Kalva SP, Salazar GM, Walker TG. Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage. Tech Vasc Interv Radiol 2009; 12: 92-101 [PMID: 19853227 DOI: 10.1053/j.tvir.2009.08.003]
67. Maleux G, Nevens F, Heye S, Verslype C, Marchal G. The use of carbon dioxide wedged hepatic venography to identify the portal vein: comparison with direct catheter portography with iodinated contrast medium and analysis of predictive factors influencing level of opacification. J Vasc Interv Radiol 2006; 17: 1771-1779 [PMID: 17142707 DOI: 10.1097/01. RVI.0000242185.26944.60]
68. Lopera JE. Role of emergency transjugular intrahepatic portosystemic shunts. Semin Intervent Radiol 2005; 22: 253-265 [PMID: 21326703 DOI: 10.1055/s-2005-925551]
69. Rubin RA, Haskal ZJ, O'Brien CB, Cope C, Brass CA. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 1995; 90: 556-563 [PMID: 7717310]
70. Sahagun G, Benner KG, Saxon R, Barton RE, Rabkin J, Keller FS, Rosch J. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Am J Gastroenterol 1997; 92: 1444-1452 [PMID: 9317060]
71. Bizollon T, Dumortier J, Jouisse C, Rode A, Henry L, Boillot O, Valette PJ, Ducerf C, Souquet JC, Baulieux J, Paliard P, Trepo C. Transjugular intra-hepatic portosystemic shunt for refractory variceal bleeding. Eur J Gastroenterol Hepatol 2001; 13: 369-375 [PMID: 11338064 DOI: 10.1097/00042737-200104 000-00011]
72. Zizka J, Eliás P, Krajina A, Michl A, Lojík M, Ryska P, Masková J, Hůlek P, Safka V, Vanásek T, Bukac J. Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients. AJR Am J Roentgenol 2000; 175: 141-148 [PMID: 10882264 DOI: 10.2214/ajr.175.1.1750141]
73. Jirkovsky V, Fejfar T, Safka V, Hulek P, Krajina A, Chovanec V, Raupach J, Lojik M, Vanasek T, Renc O, Ali SM. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency. J Vasc Interv Radiol 2011; 22: 55-60 [PMID: 21106389 DOI: 10.1016/j.jvir.2010.09.016]
74. Sze DY, Hwang GL, Kao JS, Frisoli JK, Kee ST, Razavi MK, Ahmed A. Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment. J Vasc Interv Radiol 2008; 19: 1653-1658 [PMID: 18823797 DOI: 10.1016/ j.jvir.2008.08.011]
75. Fanelli F, Salvatori FM, Rabuffi P, Boatta E, Riggio O, Lucatelli P, Passariello R. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. AJR Am J Roentgenol 2009; 193: 1696-1702 [PMID: 19933667 DOI: 10.2214/AJR.09.2968]
76. Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 2005; 16: 615-629 [PMID: 15872315 DOI: 10.1097/01. RVI.0000157297.91510.21]
77. D'Amico G, Luca A, Morabito A, Miraglia R, D'Amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 2005; 129: 1282-1293 [PMID: 16230081 DOI: 10.1053/ j.gastro.2005.07.031]
78. Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM, Rousseau H, Bosch J, Vinel JP. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27: 742-747 [PMID: 17617116 DOI: 10.1111/j.1478-3231.2007.01522.x]
79. Bañares R, Casado M, Rodríguez-Láiz JM, Camúñez F, Matilla A, Echenagusía A, Simó G, Piqueras B, Clemente G, Cos E. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998; 93: 75-79 [PMID: 9448179 DOI: 10.1111/j.1572-0241.1998.075_c.x]
80. Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Sci 1998; 43: 2463-2469 [PMID: 9824135]
81. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108: 1143-1151 [PMID: 7698582 DOI: 10.1016/0016-5085(95)90213-9]
82. Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol 2002; 13: 155-161 [PMID: 11830621 DOI: 10.1016/ S1051-0443(07)61932-0]
83. Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 165: 566-571 [PMID: 8488938 DOI: 10.1016/S0002-9610(05)80436-2]
84. McCormick PA, Dick R, Panagou EB, Chin JK, Greenslade L, McIntyre N, Burroughs AK. Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81: 1324-1327 [PMID: 7953401 DOI: 10.1002/bjs.1800810922]
85. Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving? J Hepatol 2001; 35: 658-660 [PMID: 11690713 DOI: 10.1016/S0168-8278(01)00238-0]
86. Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status. J Vasc Interv Radiol 2005; 16: 449-455 [PMID: 15802443 DOI: 10.1097/01.RVI.0000149508.64029.02]
87. Owens CA, Bartolone C, Warner DL, Aizenstein R, Hibblen J, Yaghmai B, Wiley TE, Layden TJ. The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998; 114: 975-980 [PMID: 9558286 DOI: 10.1016/ S0016-5085(98)70317-8]
88. Hirooka M, Ochi H, Koizumi Y, Kisaka Y, Abe M, Ikeda Y, Matsuura B, Hiasa Y, Onji M. Splenic elasticity measured with real-time tissue elastography is a marker of portal hypertension. Radiology 2011; 261: 960-968 [PMID: 21926379 DOI: 10.1148/radiol.11110156]
89. Gao J, Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG. The stiffness of the liver and spleen on ARFI Imaging pre and post TIPS placement: a preliminary observation. Clin Imaging 2012; 36: 135-141 [PMID: 22370134 DOI: 10.1016/ j.clinimag.2011.11.014]
90. Harman DJ, McCorry RB, Jacob RP, Lim TR, O'Neill R, Ryder SD, James MW, Aithal GP, Guha IN. Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage. Eur J Gastroenterol Hepatol 2013; 25: 201-207 [PMID: 23089879 DOI: 10.1097/ MEG.0b013e32835a4cb0]